Murphy Pohlad Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $904K | Sell |
3,594
-40
| -1% | -$8.61K | 0.32% | 80 |
|
|
2026
Q1 | $790K | Sell |
3,634
-215
| -6% | -$47.7K | 0.28% | 80 |
|
|
2025
Q4 | $879K | Hold |
3,849
| – | – | 0.34% | 70 |
|
|
2025
Q3 | $891K | Hold |
3,849
| – | – | 0.35% | 72 |
|
|
2025
Q2 | $714K | Hold |
3,849
| – | – | 0.3% | 80 |
|
|
2025
Q1 | $806K | Buy |
3,849
+2,268
| +143% | +$441K | 0.34% | 76 |
|
|
2024
Q4 | $281K | Hold |
1,581
| – | – | 0.12% | 104 |
|
|
2024
Q3 | $312K | Sell |
1,581
-194
| -11% | -$36.2K | 0.13% | 102 |
|
|
2024
Q2 | $304K | Sell |
1,775
-10
| -0.6% | -$1.66K | 0.13% | 98 |
|
|
2024
Q1 | $325K | Sell |
1,785
-50
| -3% | -$8.62K | 0.13% | 102 |
|
|
2023
Q4 | $284K | Buy |
1,835
+50
| +3% | +$7.29K | 0.12% | 102 |
|
|
2023
Q3 | $266K | Hold |
1,785
| – | – | 0.12% | 99 |
|
|
2023
Q2 | $240K | Sell |
1,785
-75
| -4% | -$11K | 0.1% | 104 |
|
|
2023
Q1 | $296K | Sell |
1,860
-175
| -9% | -$26.8K | 0.12% | 100 |
|
|
2022
Q4 | $329K | Sell |
2,035
-108
| -5% | -$16.6K | 0.13% | 100 |
|
|
2022
Q3 | $287K | Buy |
2,143
+19
| +0.9% | +$2.73K | 0.13% | 100 |
|
|
2022
Q2 | $325K | Hold |
2,124
| – | – | 0.14% | 96 |
|
|
2022
Q1 | $344K | Hold |
2,124
| – | – | 0.14% | 96 |
|
|
2021
Q4 | $287K | Hold |
2,124
| – | – | 0.11% | 100 |
|
|
2021
Q3 | $229K | Hold |
2,124
| – | – | 0.09% | 106 |
|
|
2021
Q2 | $239K | Hold |
2,124
| – | – | 0.1% | 106 |
|
|
2021
Q1 | $229K | Buy |
2,124
+50
| +2% | +$5.35K | 0.1% | 98 |
|
|
2020
Q4 | $222K | Buy |
+2,074
| New | +$199K | 0.11% | 94 |
|
|
2020
Q3 | – | Sell |
-2,074
| Closed | -$203K | – | 102 |
|
|
2020
Q2 | $203K | Buy |
+2,074
| New | +$183K | 0.11% | 96 |
|
|
2019
Q1 | – | Sell |
-2,387
| Closed | -$220K | – | 93 |
|
|
2018
Q4 | $220K | Hold |
2,387
| – | – | 0.15% | 83 |
|
|
2018
Q3 | $225K | Hold |
2,387
| – | – | 0.14% | 90 |
|
|
2018
Q2 | $221K | Hold |
2,387
| – | – | 0.15% | 85 |
|
|
2018
Q1 | $225K | Hold |
2,387
| – | – | 0.15% | 83 |
|
|
2017
Q4 | $230K | Hold |
2,387
| – | – | 0.15% | 84 |
|
|
2017
Q3 | $212K | Buy |
+2,387
| New | +$182K | 0.15% | 86 |
|
|
2015
Q4 | – | Sell |
-4,237
| Closed | -$230K | – | 93 |
|
|
2015
Q3 | $230K | Hold |
4,237
| – | – | 0.19% | 84 |
|
|
2015
Q2 | $284K | Hold |
4,237
| – | – | 0.21% | 77 |
|
|
2015
Q1 | $248K | Hold |
4,237
| – | – | 0.19% | 78 |
|
|
2014
Q4 | $277K | Hold |
4,237
| – | – | 0.2% | 80 |
|
|
2014
Q3 | $244K | Sell |
4,237
-1,600
| -27% | -$88.8K | 0.19% | 82 |
|
|
2014
Q2 | $329K | Sell |
5,837
-425
| -7% | -$22.3K | 0.25% | 76 |
|
|
2014
Q1 | $321K | Buy |
6,262
+100
| +2% | +$5.05K | 0.26% | 74 |
|
|
2013
Q4 | $325K | Hold |
6,162
| – | – | 0.27% | 72 |
|
|
2013
Q3 | $275K | Hold |
6,162
| – | – | 0.25% | 73 |
|
|
2013
Q2 | $254K | Buy |
+6,162
| New | +$269K | 0.23% | 74 |
|
Other funds holding ABBV
Murphy Pohlad Asset Management's ABBV Position: Q2 2026 in Review
Murphy Pohlad Asset Management reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $8.61K and leaving 3,594 shares worth $904K. The position accounts for 0.32% of the portfolio, ranked #80.
Murphy Pohlad Asset Management first reported a position in ABBV in Q2 2013 and has held it in 40 quarters since. 4,206 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Murphy Pohlad Asset Management held 3,594 shares of AbbVie worth $904K as of Q2 2026.
- Murphy Pohlad Asset Management sold 40 AbbVie shares in Q2 2026, an estimated $8.61K.
- AbbVie made up 0.32% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #80 holding.
- Murphy Pohlad Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 40 quarters since.
- 4,206 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.